Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Pancreatic Ductal
  • Fluorouracil
  • Pancreatic Neoplasms

abstract

  • These data suggest that adjuvant concurrent FU-based CRT significantly improves survival after PD for PC when compared with patients not receiving CRT. These data support the use of combined adjuvant CRT for PC.

publication date

  • September 15, 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3558690

Digital Object Identifier (DOI)

  • 10.1200/JCO.2007.15.8469

PubMed ID

  • 18640931

Additional Document Info

start page

  • 3503

end page

  • 10

volume

  • 26

number

  • 21